ARIAD Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals

ARIA 23.99

0.0%

Feb 17 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jongmans who wrote (614)	9/9/1999 10:16:00 AM
From: Mike McFarland	Read Replies (1) of 4474

Gosh Martin...I know you seem to think that the excess activity on a thread relates to poor stock performance--but you know that's silly--The Dell and Microsoft threads have been very active over the years... come on back good buddy. You may have even posted this already (?) A snip of the interview of James Wilson by Karen Hopkin at Biomednet--at ASGT this past June. What scientific plans do you have for the next five years? (snip) I've got about a 3-year plan--that would be for thalassemia, which is a rare form of anemia. That system--and here we're working with a group at Ariad--is based on rapamycin as a drug to activate the transgene. I'm really interested in that because scientifically it's very challenging, it's exciting. It brings together transcriptional regulation, structural biology, vectorology, immunology. So I'm spending a lot of time working and thinking about that. (snip) biomednet.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next